Published in Dig Liver Dis on July 07, 2006
Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2011) 2.32
Does chronic microaspiration cause idiopathic pulmonary fibrosis? Am J Med (2010) 1.30
Pepsin concentrations are elevated in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis after lung transplantation. J Surg Res (2013) 0.91
Blocking TGFβ via Inhibition of the αvβ6 Integrin: A Possible Therapy for Systemic Sclerosis Interstitial Lung Disease. Int J Rheumatol (2011) 0.87
Pleiotropic effect of the proton pump inhibitor esomeprazole leading to suppression of lung inflammation and fibrosis. J Transl Med (2015) 0.84
Gastroesophageal reflux and idiopathic pulmonary fibrosis: a review. Pulm Med (2010) 0.83
Bronchoalveolar pH and inflammatory biomarkers in newly diagnosed IPF and GERD patients: a case-control study. Med Sci Monit (2014) 0.82
Gastroesophageal reflux disease and graft failure after lung transplantation. Transplant Rev (Orlando) (2010) 0.82
The Role of Gastroesophageal Reflux and Microaspiration in Idiopathic Pulmonary Fibrosis. Clin Pulm Med (2014) 0.82
Protective Effect of Proton Pump Inhibitor for Survival in Patients with Gastroesophageal Reflux Disease and Idiopathic Pulmonary Fibrosis. J Neurogastroenterol Motil (2016) 0.81
Idiopathic Pulmonary Fibrosis: Novel Concepts of Proton Pump Inhibitors as Antifibrotic Drugs. Am J Respir Crit Care Med (2016) 0.78
The prevalence of gastro-esophageal reflux disease and esophageal dysmotility in Chinese patients with idiopathic pulmonary fibrosis. BMC Gastroenterol (2015) 0.78
Airway reflux, cough and respiratory disease. Ther Adv Chronic Dis (2011) 0.76
GERD and interstitial lung disease. Cause, effect, or true true and unrelated? Dig Liver Dis (2006) 0.75
Pathophysiological Studies Are Mandatory to Understand the Benefit of Proton Pump Inhibitors in Patients with Idiopathic Pulmonary Fibrosis. J Neurogastroenterol Motil (2016) 0.75
Gastroesophageal reflux and idiopathic pulmonary fibrosis: A long term relationship. Respir Med Case Rep (2016) 0.75
Risk of lung cancer in patients with gastro-esophageal reflux disease: a population-based cohort study. PeerJ (2016) 0.75
Gastroesophageal Reflux and Idiopathic Pulmonary Fibrosis. World J Surg (2017) 0.75
Lung microbiome and host immune tone in subjects with idiopathic pulmonary fibrosis treated with inhaled interferon-γ. ERJ Open Res (2017) 0.75
[Bronchopulmonary manifestations of gastroesophageal reflux disease]. Internist (Berl) (2010) 0.75
Functional gastroduodenal disorders. Gut (1999) 3.74
Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Gut (2008) 3.52
Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology (1996) 3.22
Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol (2000) 3.08
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis. Mult Scler (2006) 2.83
Endoplasmic reticulum oxidoreductin 1-lbeta (ERO1-Lbeta), a human gene induced in the course of the unfolded protein response. J Biol Chem (2000) 2.61
Chronic idiopathic intestinal pseudo-obstruction: clinical and intestinal manometric findings. Gut (1987) 2.46
Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther (2009) 2.41
Diabetes is associated with longer survival rates in patients with malignant tumors. Arch Intern Med (2000) 2.40
Manometric evaluation of functional upper gut symptoms. Gastroenterology (1985) 2.38
Development and validation of a patient-assessed gastroparesis symptom severity measure: the Gastroparesis Cardinal Symptom Index. Aliment Pharmacol Ther (2003) 2.28
One-day therapy for treatment of Helicobacter pylori infection. Dig Dis Sci (1993) 2.27
ERO1-L, a human protein that favors disulfide bond formation in the endoplasmic reticulum. J Biol Chem (2000) 2.24
Definition and investigation of dyspepsia. Consensus of an international ad hoc working party. Dig Dis Sci (1989) 2.23
Randomized clinical trial: macrogol/PEG 3350 plus electrolytes for treatment of patients with constipation associated with irritable bowel syndrome. Am J Gastroenterol (2013) 2.21
Advances in our understanding of the pathology of chronic intestinal pseudo-obstruction. Gut (2004) 2.04
Diagnosis and treatment of chronic constipation--a European perspective. Neurogastroenterol Motil (2011) 1.99
Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study. Aliment Pharmacol Ther (2009) 1.83
miR-145 participates with TP53 in a death-promoting regulatory loop and targets estrogen receptor-alpha in human breast cancer cells. Cell Death Differ (2009) 1.82
Parkinson disease: the enteric nervous system spills its guts. Neurology (2011) 1.81
Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders. Aliment Pharmacol Ther (2012) 1.79
Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index. Aliment Pharmacol Ther (1999) 1.76
Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders. Qual Life Res (2004) 1.76
Fat-storing cells as liver-specific pericytes. Spatial dynamics of agonist-stimulated intracellular calcium transients. J Clin Invest (1992) 1.71
Functional and ultrastructural features of DNA-fragmented human sperm. J Androl (2001) 1.69
Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphisms. Am J Respir Crit Care Med (2000) 1.68
Seminal vesicles ultrasound features in a cohort of infertility patients. Hum Reprod (2012) 1.62
Reversal of fundic atrophy after eradication of Helicobacter pylori. Am J Gastroenterol (1998) 1.61
JC virus infects the enteric glia of patients with chronic idiopathic intestinal pseudo-obstruction. Gut (2008) 1.59
Endoscopic markers in adult coeliac disease. Dig Liver Dis (2002) 1.58
Evaluation of GERD symptoms during therapy. Part I. Development of the new GERD questionnaire ReQuest. Digestion (2004) 1.57
A role for inflammation in irritable bowel syndrome? Gut (2002) 1.57
Impaired superoxide anion, platelet-activating factor, and leukotriene B4 synthesis by neutrophils in cirrhosis. Gastroenterology (1993) 1.55
Is intensive follow-up really able to improve prognosis of patients with local recurrence after curative surgery for rectal cancer? Ann Surg Oncol (2000) 1.55
Prospective screening of dyspeptic patients by Helicobacter pylori serology: a safe policy? The Italian Helicobacter pylori Study Group. Endoscopy (1997) 1.52
The quality of life in patients with chronic pancreatitis evaluated using the SF-12 questionnaire: a comparative study with the SF-36 questionnaire. Dig Liver Dis (2005) 1.52
Calgranulin B (S100A9) levels in bronchoalveolar lavage fluid of patients with interstitial lung diseases. Inflammation (2008) 1.48
New pathophysiological mechanisms in irritable bowel syndrome. Aliment Pharmacol Ther (2004) 1.45
The beta3-adrenoceptor agonist SR58611A ameliorates experimental colitis in rats. Neurogastroenterol Motil (2008) 1.44
Endocrine pancreatic tumors: factors correlated with survival. Ann Oncol (2005) 1.41
Stress-induced gastroduodenal motor disturbances in humans: possible humoral mechanisms. Gastroenterology (1983) 1.40
Helicobacter pylori infection and gastric function in patients with chronic idiopathic dyspepsia. Gastroenterology (1992) 1.40
Evaluation of two therapeutic regimens for the treatment of Helicobacter pylori infection. Ital J Gastroenterol (1994) 1.38
Fasting and postprandial gastrointestinal motility in ulcer and non-ulcer dyspepsia. Gut (1992) 1.38
Dose and test for dipyridamole infusion and cardiac imaging early after uncomplicated acute myocardial infarction. Am J Cardiol (1992) 1.37
Chronic intestinal pseudo-obstruction: manifestations, natural history and management. Neurogastroenterol Motil (2007) 1.35
Clinical significance of miR-144-ZFX axis in disseminated tumour cells in bone marrow in gastric cancer cases. Br J Cancer (2012) 1.33
New insights into human enteric neuropathies. Neurogastroenterol Motil (2004) 1.31
Neural topography and chronology of memory consolidation: a review of functional inactivation findings. Neurobiol Learn Mem (1999) 1.29
Identification of immunoreactive proteins of Chlamydia trachomatis by Western blot analysis of a two-dimensional electrophoresis map with patient sera. Electrophoresis (1999) 1.28
Auditory thalamus, dorsal hippocampus, basolateral amygdala, and perirhinal cortex role in the consolidation of conditioned freezing to context and to acoustic conditioned stimulus in the rat. J Neurosci (1999) 1.27
In vivo requirement for the paired domain and homeodomain of the paired segmentation gene product. Development (1996) 1.24
Humoral immune response to plasmid protein pgp3 in patients with Chlamydia trachomatis infection. Infect Immun (1994) 1.24
Pore formation by Staphylococcus aureus alpha-toxin in lipid bilayers. Dependence upon temperature and toxin concentration. Eur Biophys J (1987) 1.24
Review article: the pharmacological treatment of acute colonic pseudo-obstruction. Aliment Pharmacol Ther (2001) 1.24
Review article: molecular, pathological and therapeutic features of human enteric neuropathies. Aliment Pharmacol Ther (2008) 1.24
Functional gastrointestinal disorders and mast cells: implications for therapy. Neurogastroenterol Motil (2006) 1.23
Neutral endopeptidase (EC 3.4.24.11) terminates colitis by degrading substance P. Proc Natl Acad Sci U S A (1999) 1.22
Apoptotic cell death of human interstitial cells of Cajal. Neurogastroenterol Motil (2008) 1.20
Omeprazole, Helicobacter pylori, gastritis, and duodenal ulcer. Lancet (1989) 1.19
Role of immunologic factors and cyclooxygenase 2 in persistent postinfective enteric muscle dysfunction in mice. Gastroenterology (2001) 1.17
Gastrointestinal motility disturbances in patients with orthostatic hypotension. Gastroenterology (1985) 1.16
Relapsing ulcerative colitis after spinal cord stimulation: a case of intestinal neurogenic inflammation? Gastroenterology (1999) 1.16